A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Clinical trial NCT05501912 · TERMINATED

Trial details

NCT number: NCT05501912
Sponsor: ABM Therapeutics Shanghai Company Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor BRAF V600 Mutation

Start date: 2022-09-01
Primary completion: 2024-06-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.